
Sign up to save your podcasts
Or


The 2.3% medical device tax is burdensome. Regulatory timelines are long (and expensive). Reimbursement is not only decreasing, but also incredibly hard to obtain. Venture capitalists are losing interest in early stage medical device deals. Is it all downhill for medtech? There is no doubt the current healthcare environment is challenging. But certainly not impossible...[read more]
Related Articles
By Scott Nelson4.7
6868 ratings
The 2.3% medical device tax is burdensome. Regulatory timelines are long (and expensive). Reimbursement is not only decreasing, but also incredibly hard to obtain. Venture capitalists are losing interest in early stage medical device deals. Is it all downhill for medtech? There is no doubt the current healthcare environment is challenging. But certainly not impossible...[read more]
Related Articles

90,931 Listeners

153,546 Listeners

537 Listeners

9,538 Listeners

59 Listeners

49 Listeners

112,360 Listeners

56,503 Listeners

8,522 Listeners

21 Listeners

1,657 Listeners

16,868 Listeners

11,021 Listeners